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Objectives. We examined the vasomotility of the entire epicar- 
dial coronary artery system in patients with and without coronary 
spastic angina. 
Background. The coronary arteries of patients with variant 
angina are hyperreactive to diverse constrictor stimuli. It is 
unclear whether the abnormal responses to constrictive or dilative 
stimuli, or both, result from a localized or diffuse disorder in the 
coronary artery tree. 
Methods. Coronary artery diameter responses to intracoronary 
acetylcholine and nitroglycerin were examined at the proximal, 
middle and distal segments ofthree principal coronary arteries in 
36 patients with coronary spastic angina without significant 
stenosis and in 12 young (-<30 years old) and 20 older control 
subjects (>30 years old) with normal coronary arteriographic 
findings. In 10 patients with significant coronary stenosis, the 
responses of the prestenotic segments were also examined. 
Results. In patients with coronary spastic angina, coronary 
spasm was induced in 23 left anterior descending, 13 left circum- 
flex and 17 right coronary arteries by acetylcholine. Multivessel 
spasm was observed in 15 patients. Acetylcholine had a dilator 
effect on most segments in young control subjects and a mild 
constrictor effect in older control subjects and in patients with 
significant stenosis. Comparison of the responses to acetylcholine 
among roups demonstrated that the constrictor response of the 
artery with spasm was enhanced significantly and diffusely. That 
of the artery without spasm also tended to be enhanced. Coronary 
artery diameters after nitroglycerin did not differ in any segment 
among patients with coronary spastic angina and both control 
groups. In patients with coronary spastic angina, nitroglycerin 
significantly enhanced ilation in all segments of the artery with 
spasm compared with that observed in both control groups and in 
most segments of the artery without spasm. Patients with signif- 
icant coronary stenosis had a reduced response compared with 
that in control subjects. 
Conclusions. Hyperreactive r sponses not only to the constric- 
tor effects of acetyicholine, but also the dilator effects of nitroglyc- 
erin were detected iffusely in the epicardial coronary arteries of 
patients with coronary spastic angina. This finding indicates that 
a diffuse, not localized, disorder in vasomotility is involved in the 
pathogenesis of coronary spastic angina. 
(J Am CoU Cardiol 1996;27:45-52) 
Coronary artery spasm plays an important role in the patho- 
genesis of variant angina (1-4) and other acute coronary 
syndromes (5-7). Despite many clinical and experimental 
studies, the precise mechanism of coronary spasm is still 
unclear. The coronary arteries of patients with variant angina 
are hyperreactive to diverse constrictor stimuli (8), and occlu- 
sive constriction is readily induced by exposure to such a 
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stimulus. It is still a matter of controversy whether this 
abnormal vasomotility results from a localized (9,10) or diffuse 
disorder (11) in the epicardial coronary artery tree. MacAlpin 
(12) reported that coronary spasm occurred at a site of 
preexisting organic stenosis in most patients with variant 
angina. Because many patients with variant angina, especially 
in Japan, have normal or mildly atherosclerotic coronary 
arteries (13), it is important to clarify how diffuse the vasomo- 
tion abnormality is. 
The present study was designed to examine the constrictor 
response to acetylcholine and the dilator esponse to nitroglyc- 
erin of the proximal, middle and distal segments of the three 
major coronary arteries in patients with coronary spastic 
angina, in young and older normal control subjects and in 
patients with coronary artery disease. By analyzing the vaso- 
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Table 1. Patient Characteristics 
Control Subjects 
Young Older CSA Group CAD Group 
(n = 12) (n : 20) (n = 36) (n = 10) 
Male/female 9/3 14/6 32/4 7/3 
[ t I 
Age (yr) 21 _+ 5 59 _+ 7 55 / 9 67 +1 7 
I I 
I t I 
Total serum cholesterol (mg/dl) 185 _+ 29 189 + 34 197 + 43 230 _+ 57 
t I 
I * I 
I * I 
Systolic blood pressure (mm Hg) 
Diastolic blood pressure (mm Hg) 
114 -+ 12 135 ~ 29 131 -+ 21 137 -+ 25 
63 + 9 78-+ 19 76 + 13 73 -+ 10 
I I 
I t I 
t 
Diabetes mellitus 0 1 6 3 
Smoking 3 10 29~: 6 
*p < 0.05, tp < 0.01, ~:p < 0.01 versus other groups. Data presented are mean value ___ SD or number of patients. 
CAD = coronary artery disease; CSA = coronary spastic angina. 
motility of each coronary artery segment, we sought o ascer- 
tain whether the vasomotion abnormality in coronary spastic 
angina is localized or is present diffusely in the coronary artery 
tree. 
Methods  
S tudy  pat ients .  The study included four groups of patients 
(Table 1). Coronary spastic angina group. This group included 
36 patients with coronary spastic angina and either anglo- 
graphically normal or only mildly stenosed coronary arteries, 
with <50% lumen diameter narrowing (32 men, 4 women; 
mean age 55 years, range 38 to 69). All patients had angina at 
rest that occurred predominantly from midnight to early 
morning. Thirty-one patients howed ST segment elevation, 
whereas five showed ST segment depression, during spontane- 
ous or hyperventilation-induced anginal attacks, or both. 
Young control group. This group included 12 patients <30 
years old, with angiographically normal coronary arteries (9 
men, 3 women; mean age 21 years, range 14 to 28). These 
patients underwent cardiac atheterization because of congen- 
ital heart disease, atypical chest pain, suspected cardiomyopa- 
thy, myocarditis, mitral valve disease and idiopathic ventricular 
fibrillation. 
Older control group. This group included 20 patients ->30 
years old, with angiographically normal coronary arteries or 
minimal irregularities with <25% lumen diameter narrowing 
(14 men, 6 women; mean age 59 years, range 47 to 70). These 
patients underwent cardiac atheterization because of atypical 
chest pain. 
Coronary artery disease group. This group included 10 pa- 
tients with angiographically significant coronary artery lesions 
with >50% lumen diameter narrowing (7 men, 3 women; mean 
age 67 years, range 52 to 76). Six of these 10 patients had stable 
effort angina without previous myocardial infarction. The 
remaining four patients underwent cardiac catheterization 
because of atypical chest pain. 
No patient with atypical chest pain in the control and 
coronary artery disease groups had a clinical history suggestive 
of variant angina. Treadmill exercise and hyperventilation tests 
were performed in all of these patients, and neither anginal 
attacks nor ST segment changes were induced in any of them. 
All medications except sublingual nitroglycerin were with- 
drawn at least 3 days before the study in all study patients. No 
patient had taken nitroglycerin within 12 h of the study. An 
active smoker was asked to refrain from smoking after admis- 
sion to the hospital. No patient had congestive heart failure, 
allergy, active peptic ulcer, chronic obstructive lung disease or 
other clinically serious disease. Written informed consent was 
obtained from all patients before the study. The study was in 
agreement with the guidelines approved by the ethics commit- 
tee of our institution. 
Card iac  catheter i za t ion  and  angiographie study. Coronary 
arteriographic study was performed in the morning while the 
patients were in the fasting state. A tripolar electrode catheter 
(USCI) was inserted into the right ventricular apex and was 
connected to a temporary pacemaker set at 40 to 50 beats/min. 
Coronary arteriograms were taken in the right anterior oblique 
projection for the left coronary artery and the left anterior 
oblique projection for the right coronary artery during the 
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study period. Relations among focal spot, patient and height of 
image tube were kept constant during the angiographic study. 
Three electrocardiographic (ECG) leads (I, aVF and V3) and 
arterial pressure were continuously monitored during the 
study. Twelve leads of the ECG were recorded at appropriate 
intervals. 
Study protocol. After baseline arteriography of the left and 
right coronary arteries, intracoronary injection of acetylcholine 
was performed as described previously (14-16). In brief, 
incremental doses (50 and 100 ~g) of acetylcholine were 
injected into the left coronary artery, and the left coronary 
angiography was performed 1vain after each injection. Then, 
50 /~g of acetylcholine was injected into the right coronary 
artery, and the angiography followed. The injection time of 
each dose of acetylcholine was 20 s, and the time interval 
between injections was 5 rain. In 12 of the 36 coronary spastic 
angina group patients, 20 ~g of acetylcholine was first injected 
because baseline coronary arteriography revealed highly en- 
hanced tone. When acetylcholine-induced oronary spasm did 
not resolve spontaneously within 5 rain, or anginal chest pain 
persisted for >2 rain, or hemodynamic instability from isch- 
emia developed, nitroglycerin was administered, and the ace- 
tylcholine study was completed. Coronary spasm was defined as 
total or subtotal occlusion or severe vasoconstriction of the 
coronary artery associated with chest pain and ischemic ST 
segment changes. Finally, both the left and right coronary 
arteriograms were taken in multiple projections after admin- 
istration of nitroglycerin (0.3 rag). 
Quantitative coronary angiography. The lumen diameter of 
the coronary artery was measured quantitatively with the help 
of a computer-assisted coronary angiographic analysis ystem 
(Cardio 500, Kontron Instruments, Eching, Germany). Auto- 
mated contour detection was performed by a geometric edge 
differentiation technique (17). Details of the method were 
described in our previous study in which the technique was 
validated (18). Measurements were obtained by two indepen- 
dent investigators who were uninformed of the identify of the 
study patients. 
In both control groups and the coronary spastic angina 
group, lumen diameters were measured at the proximal, 
middle and distal segments of each of the left anterior de- 
scending, left circumflex and right coronary arteries. Each 
segment was - 1 cm long, and successively measured diameters 
within a segment were averaged. Angiographic measurements 
were obtained at baseline and after each dose of acetylcholine 
and nitroglycerin. In the coronary artery disease group, the 
diameter of the site -1.0 cm proximal to the stenotic lesion, 
where no fixed stenosis _>25% was present (prestenotic seg- 
ment), was measured. Special care was taken to perform all 
measurements a  the same site by using anatomic references. 
Any coronary artery or segment that was not suitable for 
measurement because it was hypoplastic, or because of inter- 
ference by a superimposing branch or insufficient opacification 
with contrast medium, especially in segments distal to a spasm 
site, was excluded. In three young and four older control group 
patients, acetylcholine was not injected into the right coronary 
artery. Accordingly, in the coronary spastic angina group (n = 
36), one left anterior descending, six left circumflex and five 
right coronary arteries were excluded from measurement. In 
the young control group (n = 12), two left circumflex arteries 
and three right coronary arteries were excluded. In the older 
control group (n = 20), four left circumflex arteries and six 
right coronary arteries were excluded. 
Definitions and data analysis. Coronary artery responses 
to acetylcholine and nitroglycerin were defined as percent 
diameter changes from baseline after the drugs and calculated 
as follows: 100 x (Diameter after acetylcholine or nitroglyc- 
erin - Baseline diameter)/Baseline diameter. In the coronary 
spastic angina group, coronary arteries were classified as 
arteries with and without spasm according to the response to 
acetylcholine. 
All data are shown as mean value + SD. The baseline 
coronary artery diameter, the diameter after nitroglycerin and 
the responses to 50 ~g of acetylcholine and nitroglycerin were 
compared for all coronary segments among the groups with 
one-way analysis of variance (ANOVA), followed by subse- 
quent analysis using the Fisher protected least significant 
difference multiple comparisons test. Age, total serum choles- 
terol levels, blood pressure and incidence of smoking history 
and diabetes mellitus were compared among the four groups 
with one-way ANOVA or chi-square test. A p value <0.05 was 
considered significant. 
Resu l ts  
Comparison of patient characteristics. In the coronary 
artery disease group, mean age and mean total serum choles- 
terol level were significantly higher than in the other groups 
(Table 1). Diastolic blood pressure in the young control group 
was significantly lower than that in the older control and 
coronary spastic angina groups. There was no difference in the 
incidence of diabetes mellitus among the four groups. The 
incidence of smoking history in the coronary spastic angina 
group was significantly higher than that in the other groups. Of 
the 29 coronary spastic angina group patients with a smoking 
history, 19 were active smokers at the time of hospital admis- 
sion. 
Comparison of response to acetylcholine among four study 
groups. In the coronary spastic angina group, acetylcholine 
induced spasm in 53 coronary arteries, including 23 left 
anterior descending, 13 left circumflex and 17 right coronary 
arteries. The site of spasm and the dose of acetylcholine are 
shown in Table 2. In 12 coronary spastic angina group patients, 
acetylcholine was not infused into the right coronary artery 
because nitroglycerin had been administered to resolve spasm 
induced in the left coronary artery, or the right coronary artery 
was hypoplastic. In one patient, spasm of the right coronary 
artery occurred spontaneously. Accordingly, one-vessel spasm 
was observed in 21 patients, two-vessel spasm in 12 and 
three-vessel spasm in 3 (i.e., multivessel spasm in 15 patients). 
All patients in whom spasm was induced by 20/~g of acetyl- 
choline exhibited total or subtotal coronary artery occlusion. 
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Table 2. Site of Coronary Spasm and the Dose of Acetylcholine 
Acetylcholine (p.g) 
Coronary Artery No. of 
and Segment Segments 20 50 100 
LAD 
Proximal 6 3 1 2 
Middle 15 3 4 8 
Distal 2 2 
LCx 
Proximal 4 1 3 
Middle 7 6 l 
Distal 2 1 1 
RCA 
Proximal 2 1 1 
Middle 10 2 8 
Distal 5 1 4 
LAD = left anterior descending coronary artery.; LCx left circumflex 
coronary, a f te r ;  RCA = right corona~ artery. 
Because the effect of 50 ~g of acetylcholine was not examined 
in these patients, the effect of 20/zg of acetylcholine on the 
artery with spasm was substituted for that of 50 ~g of the drug. 
Of the 54 coronary arteries other than the arteries with spasm, 
the effect of 50 ~g of acetylcholine was examined in34 arteries, 
including 12 left anterior descending, 15 left circumflex and 7 
right coronary arteries, and these arteries were defined as 
arteries without spasm. Coronary spasm was not induced by 
acetylcholine in patients in both control groups and the 
coronary artery disease group. 
Figure 1 shows a comparison of the response to 50/zg of 
acetylcholine of the proximal and middle segments of the 
coronary arteries in both control groups and those of the 
arteries with and without spasm in the coronary spastic angina 
group. In both segments of the three coronary arteries, the 
response in the young control group was significantly different 
from that in the other groups and was a dilation, except in the 
proximal segment of the left anterior descending artery. The 
response of the artery with spasm was significantly different 
from that in both control groups for all segments. Also, the 
response of the artery without spasm tended to be or was 
significantly different from that in both control groups. The 
response of the prestenotic segment in the coronary artery 
disease group was similar to that in the coronary arteries of the 
older control group. 
Comparison of response to nitroglycerin among four study 
groups. As shown in Table 3, none of the lumen diameters of 
the three segments of the three coronary arteries after nitro- 
glycerin was statistically different among the coronary spastic 
angina and both control groups. Figure 2 shows a comparison 
of the responses to nitroglycerin the proximal and middle 
segments of the three coronary arteries in both control groups 
and those of the arteries with and without spasm in the 
coronary spastic angina group. In all coronary arteries, signif- 
icant differences were observed between the young control 
group and the artery with spasm and between the older control 
group and the artery with spasm. In the left anterior descend- 
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Figure 1. Percent diameter changes inthe proximal (top) and middle 
segments (bottom) of the left anterior descending (LAD), left 
circumflex (LCX) and right coronary (RCA) arteries after intra- 
coronary injection of 50 ¢tg of acetylcholine. Data are shown for 
both control groups and for arteries with (Spasm artery) and 
without (Nonspasm artery) spasm in patients with coronary spastic 
angina. Data for the prestenotic segment inthe group with coronary 
artery disease (CAD) are also provided (bottom). See text for 
discussion. 
ing and circumflex arteries, significant differences were ob- 
served between the young control group and the artery without 
spasm and between the older control group and the artery 
without spasm. In the right coronary artery, there were signif- 
icant differences between the young control group and the 
artery without spasm. There was no statistical difference 
between the arteries with and without spasm in any of the 
proximal, middle and distal segments. 
The response to nitroglycerin i the distal segment of the 
left anterior descending artery of the coronary spastic angina 
group was significantly enhanced in both arteries with and 
without spasm compared with that in both control groups (all 
p < 0.05). The response to nitroglycerin the left circumflex 
and right coronary arteries of the coronary spastic angina 
group was significantly enhanced in the artery with spasm 
compared with that in both control groups (all p < 0.05). The 
response to nitroglycerin of the prestenotic segment in the 
coronary artery disease group was 8.5 __+ 5.7% and was not 
different from that in both control groups. 
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Table 3. Lumen Diameters ofProximal, Middle and Distal Segments ofCoronary Arteries 
After Nitroglycerin 
LAD LCx RCA 
No. of Diameter No. of Diameter No. of Diameter 
Study Group Segments (ram) Segments (mm) Segments (ram) 
Proximal segment 
Pts with CSA 
Artery with spasm 23 3.4 _+ 0.6 11 3.2 _+ 0.4 18 3.8 + 0.6 
Artery without spasm 13 3.8 + 0.5 13 3.6 _+ 1.0 14 4.2 _+ 0.7 
Young control group 12 3.8 _+ 0.8 9 4.0 + 0.7 9 3.8 +_ 0.6 
Older control group 20 3.8 + 0.6 16 3.7 _+ 0.6 14 3.8 -+ 0.6 
Middle segment 
Pts with CSA 
Artery with spasm 23 2.4 _+ 0.6 12 2.7 _+ 0.5 18 3.5 _+ 0.6 
Artery without spasm 13 2.8 + 0.4 18 2.9 _+ 0.9 14 3.8 _+ 0.7 
Young control group 12 2.8 + 0.7 11 3.1 + 0.8 9 3.3 _+ 0.5 
Older control group 20 2.7 _+ 0.4 16 3.0 + 0.4 14 3.5 _+ 0.5 
Distal segment 
Pts with CSA 
Artery with spasm 23 2.0 _+ 0.4 12 2.1 + 0.4 18 3.4 _+ 0.6 
Artery without spasm 13 2.2 _+ 0.3 13 2.1 + 0.6 14 3.4 _+ 0.7 
Young control group 12 2.2 + 0.5 11 2.2 +_ 0.6 9 2.9 + 0.6 
Older control group 20 2.1 + 0.3 16 2.2 _+ 0.3 14 3.2 -- 0.5 
Data presented are mean value _+ SD or number of segments. Abbreviations as in Tables 1 and 2. 
Discuss ion  
Diffusely enhanced coronary artery vasoreactivity in coro- 
nary spastic angina. The role of coronary spasm in the 
development of myocardial ischemia has been clarified (1-7), 
but its precise mechanism isstill unclear. It is well known that 
the coronary arteries of patients with variant angina are 
hyperreactive against diverse constrictor stimuli (8). However, 
it is controversial whether this abnormal constrictor response 
results from a localized or diffuse vasomotility disorder in the 
epicardial coronary artery tree. This distinction is important in 
research on the pathogenesis of coronary spasm, especially 
when no significant coronary artery lesion is present in the 
spasm artery. Hill et al. (9) reported that in patients with 
variant angina (most with no significant fixed stenosis), an 
exaggerated dilator response to nitroglycerin was localized to 
certain coronary segments, suggesting a localized disorder. 
Maseri et al. (10) found that both the cause and significance of 
the generalized increase in coronary vasomotility seen in some 
patients with variant angina are likely to differ from those of 
segmental occlusive spasm and should therefore be considered 
separately. Hackett et al. (19) reported that the dilator re- 
sponse to nitroglycerin of the artery with spasm in patients with 
variant angina did not differ from that of either the artery 
without spasm in the same patients or the coronary artery in 
patients without variant angina. Conversely, Hoshio et al. (11) 
showed that the coronary vasomotion disorder was present in 
the entire coronary artery tree in Japanese patients with 
suspected vasospastic angina. Kuga et al. (20) also reported 
that basal coronary artery tone of arteries with and without 
spasm in patients with variant angina is increased compared 
with that in control subjects. However, in these two previous 
studies, coronary artery diameter was measured manually, not 
quantitatively. Furthermore, coronary spasm was provoked 
with ergonovine, and nitroglycerin was administered promptly 
when spasm was induced in one of the coronary arteries. Thus, 
the distribution of abnormal vasomotility throughout all epi- 
cardial coronary arteries of the patients with coronary spastic 
angina was not clarified. 
In the present study, we quantitatively measured the lumen 
diameters of the proximal, middle and distal segments of the 
three major coronary arteries and examined the effect of 
intracoronary acetylcholine comparatively in patients with 
coronary spastic angina and in young and older control sub- 
jects. For evaluating the constrictor response of each left and 
right coronary artery separately, intracoronary acetylcholine 
has the advantage over ergonovine of an extremely short 
half-life; therefore, if spasm is induced, it resolves pontane- 
ously in many patients (21). The results showed that the 
constrictor response of the artery with spasm was significantly 
enhanced compared with that in the other groups irrespective 
of the spasm site in the three coronary arteries. The constrictor 
response of the artery without spasm also tended to be, or was, 
enhanced. These findings indicate that he constrictor response 
of the entire coronary artery system of patients with coronary 
spastic angina was diffusely enhanced. Thus, the constrictor 
response appears to be graded throughout the epicardial 
coronary arteries: In the artery without spasm, acetylcholine- 
induced vasoconstriction was not severe enough to cause 
myocardial ischemia, but in the artery with spasm, it was 
sufficiently severe to cause ischemia. The high incidence of 
multivessel coronary spasm in variant angina (21), which was 
observed in 15 of the 36 patients in the present study, further 
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Figure 2. Percent diameter changes inthe proximal (top) and middle 
segments (bottom) of the left anterior descending, left circumflex and 
right coronary arteries after nitroglycerin administration. Data are 
shown for both control groups and for arteries with and without spasm 
in patients with coronary spastic angina. Data for the prestenotic 
segment in the group with coronary artery disease are also provided 
(bottom). Abbreviations a in Figure 1. See text for discussion. 
supports the finding of diffusely enhanced constrictor response 
throughout the epicardial coronary artery tree. 
The present study also showed that the dilator esponse to 
nitroglycerin of the coronary arteries of patients with coronary 
spastic angina was significantly and diffusely enhanced com- 
pared with that in both control groups. It was also enhanced 
compared with that of the prestenotic segment of the athero- 
sclerotic oronary artery. An enhanced response to nitroglyc- 
erin was observed not only in the artery with spasm, but in the 
artery without spasm as well, with no statistical difference in 
response between them. Thus, the dilator response to nitro- 
glycerin is enhanced throughout the epicardial coronary artery 
tree in patients with coronary spastic angina compared with 
that in the other groups. In other words, basal coronary artery 
tone is increased in the entire coronary artery tree in coronary 
spastic angina, as previously demonstrated by Hoshio et al. 
(11). It should be emphasized that after nitroglycerin, each 
coronary artery segment diameter did not differ among the 
patient groups. In the control subjects, each coronary artery 
segment response to nitroglycerin was consistent with that 
reported previously (22-25). These enhanced responses to 
acetylcholine and nitroglycerin strongly suggest that a diffuse 
vasomotive abnormality hroughout the entire epicardial cor- 
onary artery tree is involved in the pathogenesis of coronary 
spasm rather than a localized disorder, at least in Japanese 
patients with coronary spastic angina and without advanced 
organic stenotic lesions. 
Possible mechanisms for diffusely enhanced vasoreactivity. 
Vascular endothelium plays an important role in the regulation 
of vascular tone by releasing both vasodilating and vasocon- 
stricting factors (26-28). In isolated coronary arteries with the 
endothelium removed, paradoxic vasoconstriction in response 
to endothelium-dependent vasodilators, uch as acetylcholine, 
and to aggregated platelets was demonstrated (29). An al- 
teration in coronary artery vasomotor esponse was also 
demonstrated in in vivo canine (30) and miniature pig models 
(31) in which the endothelium was mechanically removed. 
Endothelium-dependent vasodilation i  response to acetylcho- 
line was also impaired during the atherosclerotic process 
(32,33). The present results demonstrating vasoconstriction 
after intracoronary acetylcholine in the older control group 
and in the coronary artery disease group and vasodilation in 
the young control group were consistent with those reported 
previously (23-25) and can be explained by atherosclerosis- 
induced endothelial dysfunction present in the former groups. 
However, the diffusely exaggerated constrictor response to 
acetylcholine and coronary spasm demonstrated in patients 
with coronary spastic angina cannot be explained solely by the 
atherosclerotic process, which causes a "paradoxic" vasocon- 
strictor response to acetylcholine. 
The major endothelium-derived r laxing factor is nitric 
oxide synthesized from L-arginine (34). Moncada et al. (35) 
reported that endothelial removal or treatment with inhibitors 
of endothelial nitric oxide synthase in rat isolated aortic rings 
enhanced both the constrictor potency of phenylephrine and 
the dilator potency of nitroglycerin, a nitric oxide donor, and, 
furthermore, treatment with nitric oxide synthase inhibitors in 
anesthetized rats enhanced the hypotensive r sponse to nitro- 
glycerin without affecting that to isoproterenol. Moncada et al. 
(35) therefore indicated that inhibition of basal nitric oxide 
production leads to specific supersensitivity to nitrovasodila- 
tots. Thus, the diffusely and not regionally enhanced ilator 
response to nitroglycerin, a nitric oxide donor, demonstrated in 
the spasm and nonspasm arteries of the present patients with 
coronary spastic angina may be related to a defect in basal 
production or release of nitric oxide, or both, in the coronary 
artery endothelium. Chu et al. (36) reported that inhibition of 
nitric oxide synthase in awake dogs resulted in a reduction in 
coronary artery diameter (i.e., enhanced basal coronary artery 
tone). 
However, we (37) and other investigators (38) demon- 
strated that the coronary arteries of patients with coronary 
spastic angina responded to substance P, an endothelium- 
dependent vasodilator, similarly to those of control subjects. 
This finding does not necessarily indicate that the endothelial 
function of the coronary arteries in patients with coronary 
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spastic angina is preserved because substance P causes vasore- 
laxation through the release of not only nitric oxide, but 
hyperpolarizing factors from the vascular endothelium (39). 
Moreover, the latter factor seems to be a major mediator of 
vasorelaxation i duced by substance P (40), especially in the 
presence of inhibited nitric oxide production (41). 
Cigarette smoking is a risk factor for coronary spasm in 
Japanese patients with coronary spastic angina without signif- 
icant stenotic lesions (42) and in premenopausal white women 
with normal coronary arteriographic results and proven coro- 
nary spasm (43). The incidence of smoking history in the 
present patients with coronary spastic angina also was higher 
than among the control subjects and patients with significant 
coronary stenosis. Smoking has been shown to be associated 
with dose-related impairment ofendothelium-dependent arte-
rial dilation in asymptomatic young adults (44). Smoking 
therefore seems to be one of the factors that impairs the 
production and release of nitric oxide in the coronary arteries, 
irrespective of its atherosclerotic-promoting effect. Further 
studies of the nitric oxide synthesis ystem in the vascular 
endothelium are required to clarify the mechanisms of dif- 
fusely enhanced vasoreactivity in patients with coronary spastic 
angina. Furthermore, the contractility of coronary artery 
smooth muscle itself should be determined in conjunction with 
endothelial function. 
Limitations of the study. In 33% of patients with coronary 
spastic angina, the constrictor response to acetylcholine of the 
right coronary artery was not examined because nitroglycerin 
was administered to resolve spasm induced in the left coronary 
artery or because the right coronary artery was hypoplastic. 
Furthermore, when spasm was induced by a lower dose of 
acetylcholine in one of the left anterior descending and 
circumflex arteries, no further dose was injected into the left 
coronary artery, and thus, the response of the other vessel to a 
higher dose of acetylcholine was not evaluated. The incidence 
of multivessel spasm, therefore, may have been higher than 
that shown in the present study (42%) if acetylcholine had 
been injected into the right coronary artery and the constrictor 
response of the vessel examined in all patients with coronary 
spastic angina. Also, the constrictor response to acetylcholine 
of the coronary artery segment distal to occlusive spasm could 
not be evaluated. However, even with these limitations the 
present study still indicates that the vasomotive abnormality is 
present throughout the entire epicardial coronary artery tree 
because an enhanced ilator response to nitroglycerin was 
observed in nearly all coronary artery segments in the patients 
with coronary spastic angina. 
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